WGS GeneDx Holdings Corp.
GeneDx Holdings Corp. (WGS) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $406.9K.
Where they traded
Last open-market purchase: June 5, 2026 .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Stueland Katherine 5 fills | CHIEF EXECUTIVE OFFICER | Sell | 10,501 | $97.61 | $1.0M | 124,329 −7.8% of holding | |
| Feeley Kevin 5 fills | CHIEF FINANCIAL OFFICER | Sell | 3,728 | $97.61 | $363.9K | 48,087 −7.2% of holding | |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 3,692 | $84.22 | $310.9K | 107,227 −3.3% of holding | |
| Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 1,285 | $84.22 | $108.2K | 41,476 −3% of holding | |
| Stueland Katherine 3 fills | CHIEF EXECUTIVE OFFICER | Sell | 10,501 | $60.77 | $638.1K | 112,733 −8.5% of holding | |
| Feeley Kevin 3 fills | CHIEF FINANCIAL OFFICER | Sell | 3,729 | $60.77 | $226.6K | 42,923 −8% of holding | |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 3,639 | $53.77 | $195.7K | 96,123 −3.6% of holding | |
| Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 1,266 | $53.77 | $68.1K | 36,486 −3.4% of holding | |
| Buy | 50,000 | $52.86 | $2.6M | 3,707,164 | |||
| Buy | 150,000 | $56.44 | $8.5M | 3,657,164 | |||
| Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 369 | $51.74 | $19.1K | 35,290 −1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.